Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PSMB5 | P28074 | 1/20 | 0.33 |
| ▸ | CEL | P19835 | 1/20 | 0.32 |
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.31 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.31 |
| ▸ | PDK4 | Q16654 | 1/20 | 0.31 |
| ▸ | CASP3 | P42574 | 1/20 | 0.31 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.31 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | NCOA3 | Q9Y6Q9 | 1/20 | 0.31 |
| ▸ | CSF1R | P07333 | 1/20 | 0.31 |
| ▸ | HTR1A | P08908 | 1/20 | 0.30 |
| ▸ | HTR7 | P34969 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20172851 | 0.88 | LMNA (0.35) | CELKMT2AHTR1AHTR7 | |
| SCHEMBL20650316 | 0.88 | PSMB5 (0.33) | PSMB5CELPTGDR2PDK2PDK4 | |
| SCHEMBL20800885 | 0.85 | CEL (0.33) | PSMB5CELPDK2PDK4HTR1A | |
| SCHEMBL20172854 | 0.84 | CEL (0.36) | CELPTGDR2KMT2AHTR1AHTR7 | |
| SCHEMBL20800883 | 0.83 | HTR1A (0.33) | PSMB5CELPDK2PDK4HTR1A | |
| SCHEMBL16216708 | 0.82 | CASP3 (0.32) | PSMB5CASP3SENP7SENP6 | |
| SCHEMBL20172805 | 0.81 | CEL (0.34) | CELKMT2AHTR1AHTR7 | |
| SCHEMBL16216456 | 0.81 | CASP3 (0.30) | PSMB5CASP3SENP7SENP6 | |
| SCHEMBL23967662 | 0.80 | CYP1A2 (0.38) | — | |
| SCHEMBL20172845 | 0.80 | CEL (0.33) | CELKMT2AHTR1AHTR7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3428152-B1 | COMPOUND AND ORGANIC ELECTRONIC ELEMENT COMPRISING SAME | LG CHEMICAL LTD (KR) | 2021-11-03 | — | — | EP | disclosed |
| US-20190152919-A1 | COMPOUND AND ORGANIC ELECTRONIC ELEMENT COMPRISING SAME | LG CHEM, LTD. (KR) | 2019-05-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190152919-A1 | COMPOUND AND ORGANIC ELECTRONIC ELEMENT COMPRISING SAME | OR10J3, ETV6, ESR1 | PSMB5 4011/4885CEL 3495/4885PTGDR2 3594/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.